Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma-Reference-Cited by-同舟云学术

Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma

Published:2013-05 Issue:3 Volume:268 Page:318-330
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Puntel Mariana,A.K.M. Ghulam Muhammad,Farrokhi Catherine,VanderVeen Nathan,Paran Christopher,Appelhans Ashley,Kroeger Kurt M.,Salem Alireza,Lacayo Liliana,Pechnick Robert N.,Kelson Kyle R.,Kaur Sukhpreet,Kennedy Sean,Palmer Donna,Ng Philip,Liu Chunyan,Krasinkiewicz Johnny,Lowenstein Pedro R.,Castro Maria G.

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference78 articles.

1. Cytotoxic immunotherapy strategies for cancer: mechanisms and clinical development;Aguilar;J. Cell. Biochem.,2011

2. Inflammatory and anti-glioma effects of an adenovirus expressing human soluble Fms-like tyrosine kinase 3 ligand (hsFlt3L): treatment with hsFlt3L inhibits intracranial glioma progression;Ali;Mol. Ther.,2004

3. Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model;Ali;Cancer Res.,2005

4. Gene therapy for brain tumors: basic developments and clinical implementation;Assi;Neurosci. Lett.,2012

5. Liver-specific alpha 2 interferon gene expression results in protection from induced hepatitis;Aurisicchio;J. Virol.,2000

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA therapeutics for the treatment of blood disorders;Progress in Molecular Biology and Translational Science;2024

2. Brain Cancer Treatment; A Systematic Review;International Journal of Cancer Management;2022-07-30

3. Virotherapy treatment of central nervous system tumors;Immunotherapeutic Strategies for the Treatment of Glioma;2022

4. Current Trends in the Gene Therapy of Hematologic Disorders;Acta Medica Bulgarica;2021-11-01

5. Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy;CNS Oncology;2019-11-01